Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules

References

• Simpson C, Mu A, Haslam N, et al. Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome. J Affect Disord. 2020;266:429–446.
   PubMed Web of Science ®Google Scholar
• Fang Y, Yan C, Zhao Q, et al. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered. 2021;12(1):720–735.
   PubMed Web of Science ®Google Scholar
• Kurokawa S, Kishimoto T, Mizuno S, et al. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study. J Affect Disord. 2018;235:506–512.
   PubMed Web of Science ®Google Scholar
• Raskov H, Burcharth J, Pommergaard H, et al. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016;7(5):365–383.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu H, Chen Y, et al. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Digest Liver Dis. 2017;49(4):331–337.
   Web of Science ®Google Scholar
• Yang Z, Li J, Gui X, et al. Updated review of research on the gut microbiota and their relation to depression in animals and human beings. Mol Psychiatry. 2020;25(11):1–14.
   Web of Science ®Google Scholar
• Yu B, Qiu H, Cheng S, et al. Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting. Bioengineered. 2021;12(1):4489–4499.
   PubMed Web of Science ®Google Scholar
• Hong W, Mo Q, Wang L, et al. Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension. Bioengineered. 2021;12(1):5173–5183.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang L, Wang X, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol. 2016;14(11):1602–1611.
   PubMed Web of Science ®Google Scholar
• Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology. 2019;157(1):97–108.
   PubMed Web of Science ®Google Scholar
• Gao L, Niu X, Niu T, et al. Ganjiang granule regulates cecal microflora and serum biochemical components in a rat model of constipation-predominant irritable bowel syndrome. J Tradit Chin Med Sci. 2020;7:148–153.
   Google Scholar
• Wei Y, Zhu W, Gong J, et al. Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease. Gastroenterol Res Pract. 2015;517597.
   PubMed Web of Science ®Google Scholar
• Yang B, Chen H, Stanton C, et al. Mining bifidobacteria from the neonatal gastrointestinal tract for conjugated linolenic acid production. Bioengineered. 2021;8(3):232–238.
   Google Scholar
• Seong H, Lee S, Cheon J, et al. Fecal microbiota transplantation for multidrug-resistant organism: efficacy and response prediction. J Infection. 2020;81(5):719–725.
   PubMed Web of Science ®Google Scholar
• Sun Z, Westermann C, Yuan J, et al. Experimental determination and characterization of the gap promoter of Bifidobacterium bifidum S17. Bioengineered. 2021;5(6):371–377.
   Google Scholar
• Wortelboer K, Nieuwdorp M, Herrema H. Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine. 2019;44:716–729.
   PubMed Web of Science ®Google Scholar
• Basson A, Zhou Y, Seo B, et al. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease. Transl Res. 2020;226:1–11.
   PubMed Web of Science ®Google Scholar
• Aroniadis O, Brandt L, Oneto C, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4(9):675–685.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hausken T, Hatlebakk JG. Increasing the dose and/or repeating faecal microbiota transplantation (FMT) increases the response in patients with irritable bowel syndrome (IBS). Nutrients. 2019;11(6):1415.
   PubMed Web of Science ®Google Scholar
• Li D, Yang Y, Yin X, et al. Glucagon-like peptide (GLP) −2 improved colonizing bacteria and reduced severity of ulcerative colitis by enhancing the diversity and abundance of intestinal mucosa. Bioengineered. 2021;12(1):5195–5209.
   PubMed Web of Science ®Google Scholar
• Houte K, Colomier E, Schol J, et al. Recent advances in diagnosis and management of irritable bowel syndrome. Curr Opin Psychiatry. 2020;33:460–466.
   PubMed Web of Science ®Google Scholar
• Kang DW, Adams JB, Gregory AC, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5(1):10.
   PubMed Web of Science ®Google Scholar
• Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395–402.
   PubMed Web of Science ®Google Scholar
• Johannes P, Camille F, Marija D, et al. A microbial signature of psychological distress in irritable bowel syndrome. Psychosom Med. 2018;80:1.
   Web of Science ®Google Scholar
• Kriston L, Wolff AV. Not as golden as standards should be: interpretation of the Hamilton rating scale for depression. J Affect Disord. 2011;128(1–2):175–177.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–924.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk J, Gilja O, et al. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69(5):859–867.
   PubMed Web of Science ®Google Scholar
• Schmulson M, Bashashati M. Fecal microbiota transfer for bowel disorders: efficacy or hype? Curr Opin Pharmacol. 2018;43:72–80.
   PubMed Web of Science ®Google Scholar
• Xu D, Chen V, Steiner C, et al. Efficacy of fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2019;114(7):1043–1050.
   PubMed Web of Science ®Google Scholar
• Palma GD, Lynch M, Lu J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379):eaaf6397.
   PubMed Web of Science ®Google Scholar
• Lach G, Schellekens H, Dinan T, et al. Anxiety, Depression, and the microbiome: a role for gut peptides. Neurotherapeutics. 2018;15:36–59.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang L, Wu Y, et al. Genome-wide study of key genes and scoring system as potential noninvasive biomarkers for detection of suicide behavior in major depression disorder. Bioengineered. 2020;11(1):1189–1196.
   PubMed Web of Science ®Google Scholar
• Ventura M, Turroni F, Sinderen D. Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut. Bioengineered. 2012;3(2):73–79.
   Web of Science ®Google Scholar
• Canakis A, Haroon M, Weber H. Irritable bowel syndrome and gut microbiota. Curr Opin Endocrinol Diabetes Obes. 2020; 27(1):28-35.
   Google Scholar
• Feeney A, Sleator RD. Functional Screening of the Cronobacter sakazakii BAA-894 Genome reveals a role for ProP (ESA_02131) in carnitine uptake. Bioengineered. 2015;6(3):161–165.
   PubMed Web of Science ®Google Scholar
• Amalaradjou M, Bhunia A. Bioengineered probiotics, a strategic approach to control enteric infections. Bioengineered. 2013;4(6):379–387.
   PubMed Web of Science ®Google Scholar
• Kaakoush N. Fecal transplants as a microbiome-based therapeutic. Curr Opin Microbiol. 2020;56:16–23.
   PubMed Web of Science ®Google Scholar
• Manning T, Sleator RD, Walsh P. Biologically inspired intelligent decision making: a commentary on the use of artificial neural networks in bioinformatics. Bioengineered. 2014;5(2):80–95.
   PubMed Web of Science ®Google Scholar
• Sleator R. Under the microscope: from pathogens to probiotics and back. Bioengineered. 2015;6(5):275–282.
   PubMed Web of Science ®Google Scholar
• Chen R, Wang J, Zhan R, et al. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill. J Ethnopharmacol. 2019;244:112139.
   PubMed Web of Science ®Google Scholar
• Antushevich H. Fecal microbiota transplantation in disease therapy. Clin Chim Acta. 2020;503:90–98.
   PubMed Web of Science ®Google Scholar
• Fang Y, Yan C, Zhao Q, et al. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered. 2021;12(1):720–735.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang X, Li Y, et al. The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome. Microb Pathogen. 2021;157:104995.
   PubMed Web of Science ®Google Scholar
• Linares D, Ross P, Stanton C. Beneficial microbes: the pharmacy in the gut. Bioengineered. 2016;7(1):11–20.
   PubMed Web of Science ®Google Scholar
• Sleator RD. The synthetic biology future. Bioengineered. 2014;5(2):69–72.
   PubMed Web of Science ®Google Scholar